XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

NCT03399110 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1024

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Fudan University